Artificial Intelligence for Cardiac Ischemia Detection: A Review of Biosensor, Biomarker, and Imaging Applications
Sensors · 2026
DOI: 10.3390/s26206503 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Sensors, 2026. Verfasst von James W H Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Northwell, Cardiovascular Institute, New Hyde Park, NY 11030, USA. Hauptthemen laut MEDLINE: Myocardial Ischemia, Artificial Intelligence, Biomarkers, Biosensing Techniques. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ischemic heart disease is the leading cause of global mortality, yet accurate and timely detection remains constrained by incomplete signal capture, noise, operator dependence, and imperfect reference standards. Artificial intelligence (AI) may enhance cardiovascular sensing by extracting latent diagnostic information from routinely acquired signals. This narrative review examines AI-enabled approaches to ischemia detection across three sensing modalities: the electrocardiogram as a bioelectric sensor, cardiac troponin as a biochemical marker, and cardiac imaging technologies (echocardiography, computed tomography, magnetic resonance, and nuclear imaging) as structural and functional sensors. For each modality, we evaluate the sensing pipeline, the reference standards, the endpoint actually measured (from acute coronary occlusion to functional ischemia), and reported performance metrics, separating diagnostic accuracy from effects on clinical workflow, patient outcomes, and cost. We also discuss emerging directions, including foundation models and multimodal fusion, together with translational challenges such as limited prospective validation, regulatory hurdles, and uncertain cost-effectiveness. Most evidence comes from retrospective, frequently single-center studies of diagnostic performance; few studies have measured effects on workflow, and fewer still on patient outcomes or cost. Routine clinical adoption will require prospective multicenter trials, standardized performance benchmarks, and evidence of clinical and economic benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northwell, Cardiovascular Institute, New Hyde Park, NY 11030, USA.
- School of Cardiovascular and Metabolic Medicine and Sciences, The James Black Centre, King's College London, London SE5 9NU, UK.
- Ataraxis AI, New York, NY 10002, USA.
- Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside, New York, NY 10025, USA.
- Department of Clinical Informatics, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY 10029, USA.
ORCID-Profile: James W H Choi, Sanjay Sivalokanathan
Zitieren
APA
Choi, J. W. H., Seyam, O., Biswas, D., Sivalokanathan, S., Tai, H. H., Kong, D., & Farhan, S. (2026). Artificial Intelligence for Cardiac Ischemia Detection: A Review of Biosensor, Biomarker, and Imaging Applications. Sensors. https://doi.org/10.3390/s26206503
Vancouver
Choi JWH, Seyam O, Biswas D, Sivalokanathan S, Tai HH, Kong D, et al. Artificial Intelligence for Cardiac Ischemia Detection: A Review of Biosensor, Biomarker, and Imaging Applications. Sensors. 2026. doi:10.3390/s26206503
BibTeX
@article{Choi2026,
author = {Choi, James W H and Seyam, Omar and Biswas, Dhruva and Sivalokanathan, Sanjay and Tai, Hua-Hsin and Kong, Darren and Farhan, Serdar},
title = {Artificial Intelligence for Cardiac Ischemia Detection: A Review of Biosensor, Biomarker, and Imaging Applications},
journal = {Sensors},
year = {2026},
doi = {10.3390/s26206503}
}
EUVIMED